True North Therapeutics
Founded Year
2013Stage
Acquired | AcquiredTotal Raised
$142MValuation
$0000About True North Therapeutics
True North Therapeutics operates as a clinical-stage biopharmaceutical company. Its lead product candidate, TNT009, is designed to selectively inhibit a target in the classical complement pathway and its antibody drug development is focused on the treatment of certain rare diseases mediated by the complement system. It was founded in 2013 and is based in South San Francisco, California.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
True North Therapeutics Patents
True North Therapeutics has filed 11 patents.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
12/20/2016 | 10/29/2019 | Monoclonal antibodies, Complement system, Immune system, Immunology, Acetylcholinesterase inhibitors | Grant |
Application Date | 12/20/2016 |
|---|---|
Grant Date | 10/29/2019 |
Title | |
Related Topics | Monoclonal antibodies, Complement system, Immune system, Immunology, Acetylcholinesterase inhibitors |
Status | Grant |
Latest True North Therapeutics News
Mar 16, 2020
The information provided by BioPortfolio.com is not a substitute for professional medical advice, diagnosis or treatment. The BioPortfolio site is sponsored ND2A Group with offices at 677 Craig Rd, Suite 216, Creve Coeur, Missouri 63141 USA. If you are a legal copyright holder or a designated agent for such and you believe a post on this website falls outside the boundaries of “Fair Use” and legitimately infringes on your or your client's copyright we may be contacted concerning copyright matters here: Contact ND2A Group . All rights reserved. All other trademarks recognized. Copyright © 2020 ND2A Group. Site developed by Alacrify Ltd .
True North Therapeutics Frequently Asked Questions (FAQ)
When was True North Therapeutics founded?
True North Therapeutics was founded in 2013.
Where is True North Therapeutics's headquarters?
True North Therapeutics's headquarters is located at 951 Gateway Boulevard, South San Francisco.
What is True North Therapeutics's latest funding round?
True North Therapeutics's latest funding round is Acquired.
How much did True North Therapeutics raise?
True North Therapeutics raised a total of $142M.
Who are the investors of True North Therapeutics?
Investors of True North Therapeutics include Bioverativ, Perceptive Advisors, HBM Healthcare Investments, Franklin Templeton, Redmile Group and 12 more.
- Predict emerging trends
- See competitors' playbooks
- Stalk the smart money
- Identify tomorrow's challengers
- Spot growing industries
- Kill analyst data work
Discover the right solution for your team
The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.
